Clinical Trial Update: SIRT and Peri-immunotherapy : a New Concept

View source ↗

Summary

A clinical trial update describes a study of combining selective internal radiation therapy with peri-immunotherapy for advanced hepatocellular carcinoma (BCLC …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Advanced Hepatocellular Carcinoma (HCC), Classified as BCLC Stage B or C, Treated With a Combination of Selective Internal Radiation Therapy | Status: NOT_YET_RECRUITING